Skip to main content

$5.19 0.12 (2.37%)

High

$5.29

Low

$5.12

Trades

1,945

Turnover

$3,576,754

Volume

686,116
30 June 2023 at 4:10pm
Register to track AVH and receive email alerts.
Subject
AVH Ann: Notification regarding unquoted securities - AVH

AVH Ann: AVITA Medical Melbourne Investor Briefing

AVH Ann: AVITA Medical at the Piper Sandler Healthcare Conference

AVH Ann: AVITA Medical to Host Investor Webinar Briefing

AVH Ann: Change of Director's Interest Notice - Michael Perry

AVH Ann: Quarterly Financial Report Form 10-Q

AVH Ann: AVITA Medical Reports Third Quarter 2022 Financial Results

AVH Ann: Co-Primary Endpoints Met in RECELL Soft Tissue Repair Trial

AVH Ann: Statement of CDIs on issue - AVH

AVH Ann: Notification of cessation of securities - AVH

AVH Ann: FDA Grants Breakthrough Device Designations to RECELL System

AVH Ann: AVITA Medical to Announce Third Quarter Financial Results

AVH Ann: Definitive Proxy Statement

AVH Ann: Notification regarding unquoted securities - AVH

AVH Ann: Statement of CDIs on issue - AVH

AVH Ann: Notification of cessation of securities - AVH

AVH Ann: Form 8-K Material terms of CEO's Employment Agreement

AVH Ann: AVITA Medical Appoints James Corbett as CEO

AVH Ann: Ceasing to be a substantial holder

AVH Ann: AVITA Medical Investor Webinar Briefing Deck

AVH Ann: Investor Webinar Briefing

AVH Ann: Positive Trial Results Treating Stable Vitiligo With RECELL

AVH Ann: Change of Director's Interest Notice - Michael Perry

AVH Ann: Notice under section 708A(5)(e) of the Corporations Act

AVH Ann: Notification regarding unquoted securities - AVH

AVH Ann: Statement of CDIs on issue - AVH

AVH Ann: Notification of cessation of securities - AVH

AVH Ann: RECELL Insurance Coverage Begins in Japan for Acute Burns

AVH Ann: AVITA Medical Corporate Deck August 2022

AVH Ann: Notice under section 708A(5)(e) of the Corporations Act

AVH Ann: Notification regarding unquoted securities - AVH

AVH Ann: RECELL Presentations at Laser & Cosmetic Surgery Meeting

AVH Ann: Half Year Financial Report Form 10-Q

AVH Ann: AVITA Medical Topline Results from Soft-Tissue Pivotal Trial

AVH Ann: AVITA Medical Reports Second Quarter 2022 Financial Results

AVH Ann: Statement of CDIs on issue - AVH

AVH Ann: Notification of cessation of securities - AVH

AVH Ann: AVITA to Announce Second Quarter 2022 Financial Results

AVH Ann: Notification regarding unquoted securities - AVH

AVH Ann: Ceasing to be a substantial holder

AVH Ann: Notification regarding unquoted securities - AVH

AVH Ann: Statement of CDIs on issue - AVH

AVH Ann: Notification of cessation of securities - AVH

AVH Ann: Change of Director's Interest Notice - Michael Perry

AVH Ann: Notice under section 708A(5)(e) of the Corporations Act

AVH Ann: Notification regarding unquoted securities - AVH

AVH Ann: Statement of CDIs on issue - AVH

AVH Ann: Notification of cessation of securities - AVH

AVH Ann: AVITA Medical Investor Webinar

AVH Ann: Quarterly Financial Report (Form 10-Q)

Register to track AVH and receive email alerts.